Trial Profile

Efficacy and safety study of SPX-001 for influenza in participating healthy adults

Status: Not yet recruiting

Phase of Trial: Phase I

Latest Information Update: 07 Dec 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs SPC-069 (Primary)
Indications COVID 2019 infections; Respiratory tract infections
Focus Adverse reactions; First in man; Proof of concept
Sponsors SpectrumX

Most Recent Events

07 Dec 2023 The trial recruitment end date was found to be 27/06/2025
07 Dec 2023 Planned End Date changed to 27 Jun 2026.
07 Dec 2023 Planned initiation date changed from 1 Jun 2023 to 20 Jun 2023.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com